Friday, 19th April 2019

Molecular Neuropathology

      Genetic bases of Alzheimer's Disease: Genomic study of pathogenic cell models.

 

 

Grupo-400
 


María Jesús Bullido

DSciStaff

DPublications

 

Research summary:

In the last years our group has focused on the search of risk factors and/or genes involved in the Alzheimers disease (AD), developing cellular models to obtain candidates that are then validated through genetic association studies in patients. One of the main objectives of the group is to establish the involvement in the pathogenesis of AD of two factors associated with aging, oxidative stress (OS) and infection by HSV 1.

-------- Fig01-300
  Oxidative stress produces the accumulation of APP protein and its carboxi and amino terminal fragments in SK N MC neuronal cells.

We have found that in the cell models OS regulates the traffic, degradation and proteolytic processing of the peptide Aβ precursor protein (APP), and that this regulation involves the two main cellular proteolytic systems: ubiquitin/proteasome and autophagy/lysosome. On the other hand, HSV-1 is able to reproduce most of the anomalies found in the brains of AD patients, as the hyperphosphorylation of tau protein and alterations of the autophagic process that lead to the intracellular accumulation of Aβ; these effects are increased in the presence of OS.
After the genomic analysis of the cell models, we have focused on the list of genes which expression is modulated by HSV 1 in the presence of OS because this is similar to the infection in aged people for their functional validation and genetic risk association studies. The "cytokine-mediated inflammation" function is highly enriched in this list, which is consistent with the findings of the latest genome wide association studies (GWAs) and suggests that HSV 1 may participate in the pathogenesis of sporadic AD.

Other works of the group during this period include the analysis of cellular models of monogenic AD, and the participation in collaborative genetic association studies, mainly with groups of CIBERNED and as part of the European consortium EADI, which are revealing novel AD risk factors..


 

Publications:

  • Kristen H, Sastre I, Muñoz-Galdeano T, Recuero M,Aldudo J, Bullido MJ (2018) The lysosome system is severely impaired in a cellular model of neurodegeneration induced by HSV-1 and oxidative stress. Neurobiol Aging 68: 5-17.
    Kristen H, Santana S, Sastre I, Recuero M, Bullido MJ, Aldudo J (2015) Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells. Neurobiol Aging 36(10): 2737-2747.
  • Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW et al. Bullido MJ (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49(9):1373-1384.
  • Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WS, Haas J, Hudson AP, Kamer AR, Kell DB, Licastro F, Letenneur L, Lövheim H, Mancuso R, Miklossy J, Otth C, Palamara AT, Perry G, Preston C, Pretorius E, Strandberg T, Tabet N, Taylor-Robinson SD, Whittum-Hudson JA (2016) Microbes and Alzheimer's Disease. J Alzheimers Dis 51(4): 979-84.
  • Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, et al. (2016) Microbes and Alzheimer's disease. J Alzheimers Dis 51(4): 979-984.
  • Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, et al. Bullido MJ. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21(1): 108-17.
  • Pastor P, Moreno F, Clarimón J, Ruiz A, Combarros O, Calero M, De Munain AL, Bullido MJ, et al (2015). MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium. J Alzheimers Dis 49(2): 343-352.
  • Jones L, Lambert JC, Wang LS, Choi SH, Harold D, Vedernikov A, et al. Bullido MJ (2015) Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimers & Dementia 11(6): 658-671.
  • Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodríguez-Rodríguez E, et al. (2014) Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Neurobiol Aging 35: 444 e1-4.
  • Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45: 1452-8.
  • Santana S, Sastre I, Recuero M, Bullido MJ, Aldudo J (2013) Oxidative stress enhances neurodegeneration markers induced by herpes simplex virus type 1 infection in human neuroblastoma cells. PLoS One 8: e75842.
  • Recuero M, Munive VA, Sastre I, Aldudo J, Valdivieso F, et al. (2013) A free radical-generating system regulates AbetaPP metabolism/processing: involvement of the ubiquitin/proteasome and autophagy/lysosome pathways. J Alzheimers Dis 34: 637-647.
  • Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J (2012) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging 33: 430 e419-433.
  • Santana S, Bullido MJ, Recuero M, Valdivieso F, Aldudo J (2012) Herpes simplex virus type I induces an incomplete autophagic response in human neuroblastoma cells. J Alzheimers Dis 30: 815-831.
  • Recuero M, Munoz T, Aldudo J, Subias M, Bullido MJ, et al. (2010) A free radical-generating system regulates APP metabolism/processing. FEBS Lett 584: 4611-4618.
  • Recuero M, Vicente MC, Martinez-Garcia A, Ramos MC, Carmona-Saez P, et al. (2009) A free radical-generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease. Aging Cell 8: 128-139.

 


 

Awards:

- Fundación Madrid+D. Premio a las mejores patentes; accésit. (2011)
- Sociedad Madrileña de Neurología. Premio Ramón y Cajal de Investigación básica (2011)

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: